JPS61185193A - Production of l(+)-beta-hydroxyfatty acid - Google Patents
Production of l(+)-beta-hydroxyfatty acidInfo
- Publication number
- JPS61185193A JPS61185193A JP2584285A JP2584285A JPS61185193A JP S61185193 A JPS61185193 A JP S61185193A JP 2584285 A JP2584285 A JP 2584285A JP 2584285 A JP2584285 A JP 2584285A JP S61185193 A JPS61185193 A JP S61185193A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- substrate
- fatty acids
- microorganism
- beta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は、微生物を利用した、2種の異なる官能基を有
し、医薬、農薬などの有用な合成中間体であるL(−1
−)−β−ヒドロキシ脂肪酸の製造法に関し、更に詳し
くはキャンデイダ属あるいはデバリオマイセス属に属し
、酪酸をL(ト)−β−ヒドロキシ酪酸に変換する能力
を有する微生物から誘導されたL(−1−)−β−ヒド
ロキシ酪酸を単一炭素源とする栄養培地に生育しないか
、もしくは生育の弱い変異株を、炭素数4あるいは5の
飽和脂肪酸、あるいはα、β−不飽和脂肪酸またはアル
コールに作用させ、生成する炭素数4あるいは5のL(
ト)−β−ヒドロキシ脂肪酸を採取することを特徴とす
るL(ト)−β−ヒドロキシ脂肪酸の製造法に関する。Detailed Description of the Invention (Industrial Field of Application) The present invention provides L(-1
Regarding the method for producing -)-β-hydroxy fatty acids, more specifically L(-1- )-A mutant strain that does not grow or grows weakly in a nutrient medium containing β-hydroxybutyric acid as the sole carbon source is reacted with saturated fatty acids having 4 or 5 carbon atoms, α, β-unsaturated fatty acids, or alcohol. , L with 4 or 5 carbon atoms to be produced (
The present invention relates to a method for producing L(t)-β-hydroxy fatty acids, which comprises collecting g)-β-hydroxy fatty acids.
(従来の技術と問題点)
炭素数4個のL(ト)−β−ヒドロキシ酪酸の製造法に
関しては、アセト酢酸エチルをパン酵母による不斉還元
によりL(ト)−β−ヒドロキシ酪酸エチルとして得る
方法等が知られているが(森ら:日本化学会誌第9号、
1315頁、1983年)、多量の酵母を必要とし経済
的な方法とは考え難い。(Prior art and problems) Regarding the production method of L(t)-β-hydroxybutyric acid having 4 carbon atoms, ethyl acetoacetate is asymmetrically reduced using baker's yeast to produce ethyl L(t)-β-hydroxybutyrate. There are known methods to obtain it (Mori et al.: Journal of the Chemical Society of Japan, no.
1315, 1983), it requires a large amount of yeast and is difficult to consider as an economical method.
一方、炭素数5個のL(+)−β−ヒドロキシ吉草酸の
製法に関してはβ−ケト吉草酸エチルをパン酵母還元に
よりD(ハ)−β−ヒドロキシ吉草酸エチルとして得る
方法が知られているがクレータ−ら、ヘルベテイカ キ
ミカ アクタCG、Frater。On the other hand, regarding the production method of L(+)-β-hydroxyvaleric acid having 5 carbon atoms, a method is known in which ethyl β-ketovalerate is obtained as D(c)-β-ethyl valerate by reduction with baker's yeast. Iruga Crater et al., Helvetica Kimika Acta CG, Frater.
He1vetica Chimica Acta) 6
2巻、2829頁、1973年〕、立体配置が逆である
。He1vetica Chimica Acta) 6
2, p. 2829, 1973], the configuration is reversed.
本発明者らは、先にキャンデイダ・ルゴーザ(Cand
Ida rugosa) I F 0 1542により
吉草酸からL(ト)−β−ヒドロキシ吉草酸を生産しう
ることを見い出しているが(特公昭59−53838)
。The present inventors previously discovered Candida Rugoza (Candida Rugoza)
It was discovered that L(t)-β-hydroxyvaleric acid could be produced from valeric acid by Ida rugosa) I F 0 1542 (Japanese Patent Publication No. 59-53838).
.
通常の微生物は直鎖状のL(ト)−β−ヒドロキシ脂肪
酸を極めて容易に代謝するために収率が極めて低く、大
量生産にはむかない。Ordinary microorganisms metabolize linear L(t)-β-hydroxy fatty acids very easily, resulting in extremely low yields, making them unsuitable for mass production.
そこで本発明者らは、安価で、かつ効率的なL(+)−
β−ヒドロキシ脂肪酸の製造法を開発すべく研究の結果
、サツカロマイコピシス属、エンドマイセス属、あるい
はピキャ属に属し、酪酸をL(+)−β−ヒドロキシ酪
酸に変換する能力を有する微生物を変異改良し、L(−
1−1−β−ヒドロキシ酪酸を単一炭素源とする栄養培
地に生育しない変異株に誘導することにより、酪酸、ク
ロトン酸あるいはn−ブチルアルコールからL(+)−
β−ヒドロキシ酪酸を、吉草酸、2−ペンテン酸あるい
はn−アミルアルコールからL(+)−β−ヒドロキシ
吉草酸を高収率に生産しうろことを見い出して、既に特
許出願(特願昭59−44753)しているが、更に検
討を重ねた結果、このような能力を有する変異株として
、キャンデイダ属、あるいはデバリオミセス属に属する
微生物の変異株を見出し、本゛発明を完成した。Therefore, the present inventors have developed an inexpensive and efficient L(+)-
As a result of research to develop a method for producing β-hydroxy fatty acids, we mutated microorganisms belonging to the genus Satucharomycopisis, Endomyces, or Pica that have the ability to convert butyric acid to L(+)-β-hydroxybutyric acid. Improved, L(-
By inducing a mutant strain that does not grow on a nutrient medium containing 1-1-β-hydroxybutyric acid as the sole carbon source, L(+)-
He discovered that β-hydroxybutyric acid can be used to produce L(+)-β-hydroxyvaleric acid in high yield from valeric acid, 2-pentenoic acid, or n-amyl alcohol, and has already applied for a patent (Patent Application No. 59, 1983). -44753), but as a result of further investigation, we discovered a mutant strain of a microorganism belonging to the genus Candida or the genus Debaryomyces as a mutant strain having such an ability, and completed the present invention.
(問題点を解決するための手段)
本発明を実施するに当り、変異株取得のために用いられ
る親株として、キャンディダ・パラルゴーザ(Cand
ida pararugosa) I F OO966
゜デバIJ tマイセス・ハンセンニ(Debaryo
mycashansen目)IFo 0032等があ
るが、酪酸をL(ト)−β−ヒドロキシ酪酸に、吉草酸
をL(ト)−β−ヒドロキシ吉草酸に変換する能力を有
する微生物であればいずれも用いることができる。(Means for Solving the Problems) In carrying out the present invention, Candida paralgosa (Candida paralgosa) is used as a parent strain to be used for obtaining mutant strains.
ida pararugosa) I F OO966
゜Debaryo IJ tMyces Hansenni (Debaryo
Mycashansenales) IFo 0032, etc., but any microorganism can be used as long as it has the ability to convert butyric acid to L(t)-β-hydroxybutyric acid and valeric acid to L(t)-β-hydroxyvaleric acid. I can do it.
微生物と基質とを作用させL(ト)−β−ヒドロキシ脂
肪酸に変換させる方法としては、微生物を栄養培地で培
養し、得られた培養液に、あるいは培養液から微生物を
分離して菌体懸濁液を調製し、それに基質を反応させる
方法、あるいは基質を添加した培地で微生物を培養する
ことにより微生物と基質を反応させる方法等がある。ま
た分離菌体は水不溶性ポリマー等で固定化した状態でも
使用しうる。As a method for converting microorganisms into L(t)-β-hydroxy fatty acids by interacting with a substrate, microorganisms are cultured in a nutrient medium, and microorganisms are separated from the culture solution or culture solution and the microorganisms are suspended. There are methods such as preparing a suspension and reacting it with a substrate, or culturing microorganisms in a medium to which a substrate is added, and then reacting the microorganisms with the substrate. The isolated bacterial cells can also be used in a state where they are immobilized with a water-insoluble polymer or the like.
微生物と基質との接触反応時に該微生物が利用しうるエ
ネルギー源を補給することによりL(ト)−β−ヒドロ
キシ脂肪酸の生産性は向上する。この際Iこ好ましいエ
ネルギー源としてはグルコース、グリセロール等がある
。The productivity of L(t)-β-hydroxy fatty acids is improved by supplying an energy source that can be used by the microorganisms during the contact reaction between the microorganisms and the substrate. In this case, preferred energy sources include glucose, glycerol, and the like.
通常の微生物はL(−1−)−β−ヒドロキシ脂肪酸の
代謝速度が早いため、L粕−β−ヒドロキシ脂肪酸の蓄
積量は極めて少なく、経済的に生産することは困難であ
る。そこで効率的に多量蓄積させるには、L(ト)−β
−ヒドロキシ脂肪酸の代謝速度が遅いか、もしくは代謝
しない変異株、換言すればL(ト)−β−ヒドロキシ脂
肪酸を単一炭素源とする栄養培地に生育しないか、もし
くは生育の弱い変異株を使用することが有利である。Since ordinary microorganisms have a fast metabolic rate of L(-1-)-β-hydroxy fatty acids, the amount of L-lees-β-hydroxy fatty acids accumulated is extremely small, making it difficult to produce them economically. Therefore, in order to efficiently accumulate a large amount, L(t)−β
-Use a mutant strain that has a slow metabolic rate of hydroxy fatty acids or does not metabolize them, in other words, a mutant strain that does not grow or grows weakly in a nutrient medium containing L(t)-β-hydroxy fatty acids as the sole carbon source. It is advantageous to do so.
この様な変異株を得るには人工変異あるいは自然変異を
利用するが、効率的に行なうには通常人工変異が用いら
れる。人工変異方法としては、X線照射、紫外線照射、
r線処理、詔よびN−メチル−N−二トローN′−二ト
ロソグアニジン(NTG)などの変異誘起剤による処理
が用いられる。具体的な例として本発明者らがL(ト)
−β−ヒドロキシ脂肪酸を代謝しない変異株を得るため
に行ったNTGによる変異方法の1例について示すと、
次のとセリである。ただし、目的とする変異株が得られ
れば良いのであって、この方法に限定されるものではな
い。Artificial mutation or natural mutation is used to obtain such mutant strains, but artificial mutation is usually used for efficient mutation. Artificial mutation methods include X-ray irradiation, ultraviolet irradiation,
Treatment with r-rays, treatment with mutagenic agents such as N-methyl-N-nitro-N'-nitrosoguanidine (NTG) are used. As a specific example, the present inventors
An example of the NTG mutation method used to obtain a mutant strain that does not metabolize -β-hydroxy fatty acids is as follows:
The next one is auction. However, the method is not limited to this method as long as the desired mutant strain can be obtained.
保存用スラント(キャンデイダ・パラルゴーザIF0
0966)から1白金耳をグルコース40?、(NH4
)2HPO4131P、KH2PO47y、MgSO4
・7H200,8y、ZnSO44H2060fttg
、FeSO4’7H2090fng、CuSO4・5H
2051+19.MnSO4・4H201011v、
NaC10,1y、ビオチンpもチアミン−−HCl2
)n、水1/、pH7,2の組成からなるS培地3〇−
を500−容フラスコに入れ接種し、30℃。Preservation slant (Candida paralgoza IF0
0966) to 1 platinum loop of glucose 40? , (NH4
)2HPO4131P, KH2PO47y, MgSO4
・7H200, 8y, ZnSO44H2060fttg
, FeSO4'7H2090fng, CuSO4・5H
2051+19. MnSO4・4H201011v,
NaC10,1y, biotin p also thiamine--HCl2
) n, water 1/, pH 7,2 S medium 30-
was inoculated into a 500-volume flask and heated at 30°C.
20時時間上う培養した。その培養液1.51nlを0
.5Mリン酸緩衝液(pH7,0)で洗浄後、0.5f
nq/1nlNTG溶液3rnlに懸濁し、4℃、60
分間放置した。その後、同じ緩衝液で3回洗浄し、次の
組成からなる固形平板培地C培地(グルコース202、
イーストエキス5y、肉エキスl(1,ペプトン10y
、寒天20y、水11 、 pH7,0)に塗布し、コ
ロニーを出現させた。このコロニーをS培地のグルコー
スの代りに酪酸10y、寒天202を加えたpH7,0
のS培地にレプリカし、30℃で2日間培養した。この
S培地上で生育不良の菌(酪酸非資化性味)を選んだ。The cells were incubated for 20 hours. 1.51 nl of the culture solution was
.. After washing with 5M phosphate buffer (pH 7,0), 0.5f
Suspended in 3rnl of nq/1nlNTG solution, 4°C, 60
Leave it for a minute. Thereafter, the solid plate medium C (glucose 202, glucose 202,
Yeast extract 5y, meat extract 1 (1, peptone 10y
, agar 20y, water 11%, pH 7.0) and colonies were allowed to appear. This colony was added to S medium containing 10 y of butyric acid and 20 y of agar instead of glucose at pH 7.0.
The cells were replicated onto S medium and cultured at 30°C for 2 days. Bacteria that grew poorly on this S medium (non-butyric acid assimilation) were selected.
この様にして得た酪酸非資化性味をS培地に植え、30
℃、48時間培養し、L(ト)−β−ヒドロキシ酪酸の
生産をガスクロマトグラフィー法〔長谷用ら;ジャーナ
ル・オブ・ファーメンティジョン・テクノロジー(J
、 Ferm 、Tech、 )誌59巻、257頁、
1981年〕テ分析し、L(ト)−β−ヒドロキシ酪酸
生産株を選んだ。この様にして選んだ変異株はL(ト)
−β−ヒドロキシ酪酸を単一炭素源とする栄養培地(例
えばS培地のグルコースの代りにL(ト)−β−ヒドロ
キシ酪酸を添加した培地)での生育が著しく低下して怠
り、本発明に使用できる。他の属の微生物の変異も同様
な手法を用いて行なう事ができ、本発明を実施するため
に上記方法で得た変異株の例として、キャンディダ・パ
ラルゴーザ(Candida pararugosa)
KT 84015、デバリオマイセス・ハンセンニ
(Debaryomyceshansenji ) K
T 84016等がある。この変異株の性質としては
親株と殆んど差が認められなし)が、表−1に示すと怠
りL(ト)−β−ヒドロキシ脂肪酸の資化性に諮いて著
しい差が認められた。The non-assimilated butyric acid flavor obtained in this way was planted on S medium, and
℃ for 48 hours, and the production of L(t)-β-hydroxybutyric acid was determined by gas chromatography [Haseyo et al.; Journal of Fermentation Technology (J
, Ferm, Tech, ) volume 59, page 257,
1981] and selected L(t)-β-hydroxybutyric acid producing strains. The mutant strain selected in this way is L (t)
-Growth on a nutrient medium containing β-hydroxybutyric acid as the sole carbon source (for example, a medium in which L(t)-β-hydroxybutyric acid is added instead of glucose in S medium) is significantly reduced and the present invention is not suitable. Can be used. Mutations of microorganisms of other genera can be carried out using similar techniques, and as an example of a mutant strain obtained by the above method for carrying out the present invention, Candida pararugosa (Candida pararugosa) is used.
KT 84015, Debaryomyces hansenji K
There are T 84016 etc. There was almost no difference in the properties of this mutant strain from that of the parent strain), but as shown in Table 1, there was a significant difference in the ability to assimilate L(t)-β-hydroxy fatty acids.
表 −1
MS培地において、それぞれの化合物を単一の炭素源と
して1チ添加して培養(30℃、4日間)した。Table 1 In MS medium, 1 g of each compound was added as a single carbon source and cultured (30°C, 4 days).
冊 :生育良好 −二生育不良
なお、これらの変異株は、表−2に示すとおり、工業技
術院微生物工業技術研究所に下記の番号で寄託しである
。Book: Good growth - 2 Poor growth These mutant strains have been deposited with the following numbers at the Institute of Microbial Technology, Agency of Industrial Science and Technology, as shown in Table 2.
表 −2
本発明に使用する微生物培養用培地は、グルコース、グ
リセロール等の炭素源、アンモニア、硫安。Table 2 The microorganism culture medium used in the present invention contains carbon sources such as glucose and glycerol, ammonia, and ammonium sulfate.
ペプトン、カザミノ酸等の無機・有機の含窒素化合物の
窒素源、リン酸カリウム、硫酸マグネシウム等生育に必
要な無機塩類、更にビオチン等のビタミン類、その他必
要に応じて通常の微生物培養に用いられる種々の栄養源
を適宜配合して用いることができる。培養には殺菌した
培地に菌を接種し、20〜45℃の温度でpH6〜9に
保ちつつ1〜10日間通気撹拌、振とう培養等好気的に
行なう。培養初期に菌体生産があり、その後L(ト)−
β−ヒドロキシ脂肪酸の生産が行なわれる。またL(ト
)−β−ヒドロキシ脂肪酸の生産時にエネルギー源とし
てグルコースまたはグリセロール等を補給することによ
り、より効率的にL(ト)−β−ヒドロキシ脂肪酸の生
産が行なわれる。基質は培養初期から培地に加えても、
菌体生育後に添加しても、いずれでも良い。Nitrogen sources such as inorganic and organic nitrogen-containing compounds such as peptone and casamino acids, inorganic salts necessary for growth such as potassium phosphate and magnesium sulfate, vitamins such as biotin, and others used for normal microbial culture as necessary. Various nutrient sources can be appropriately mixed and used. For culturing, bacteria are inoculated into a sterilized medium, and culture is carried out aerobically, such as with aeration and shaking, for 1 to 10 days while maintaining the pH at 6 to 9 at a temperature of 20 to 45°C. There is bacterial cell production in the early stage of culture, and then L(t)-
Production of β-hydroxy fatty acids takes place. Furthermore, by supplying glucose, glycerol, or the like as an energy source during the production of L(t)-β-hydroxy fatty acids, L(t)-β-hydroxy fatty acids can be produced more efficiently. Even if the substrate is added to the medium from the early stage of culture,
It may be added after the bacterial cells have grown.
培養液あるいは菌体反応液から生成したL(ト)−β−
ヒドロキシ脂肪酸を回収するには、通常のβ−ヒドロキ
シ脂肪酸の回収に用いる手段によって行なうことができ
る。例えば菌体除去後、L(−1−)−β−ヒドロキシ
脂肪酸含有液を濃縮後、硫酸等でpH2,5以下にし、
これよりエーテル、酢酸エチル等で抽出し、溶剤を除去
後、減圧蒸留することによりL(ト)−β−ヒドロキシ
脂肪酸をうることができる。L(ト)−β−ヒドロキシ
脂肪酸は余り安定な物質でないので、前記の溶剤抽出等
で得たL(−1−1−β−ヒドロキシ脂肪酸をメタノー
ルやエタノール等のアルコールに溶解し、硫酸等の触媒
存在下で加熱すれば容易にアルキルエステルに変換しう
る。L(t)-β- produced from culture solution or bacterial cell reaction solution
Hydroxy fatty acids can be recovered by means commonly used for recovering β-hydroxy fatty acids. For example, after removing the bacterial cells, concentrating the L(-1-)-β-hydroxy fatty acid-containing liquid and adjusting the pH to 2.5 or less with sulfuric acid, etc.
L(t)-β-hydroxy fatty acid can be obtained by extracting this with ether, ethyl acetate, etc., removing the solvent, and then distilling it under reduced pressure. Since L(t)-β-hydroxy fatty acid is not a very stable substance, the L(-1-1-β-hydroxy fatty acid obtained by the above solvent extraction etc.) is dissolved in alcohol such as methanol or ethanol, and then extracted with sulfuric acid etc. It can be easily converted into an alkyl ester by heating in the presence of a catalyst.
このものを蒸留すれば高収率に高純度のL(ト)−β−
ヒドロキシ脂肪酸エステルを得ることができ、このエス
テル体は比較的安定である。If this product is distilled, high yield and high purity L(t)-β-
Hydroxy fatty acid esters can be obtained, and these esters are relatively stable.
(発明の効果)
本発明により光学活性L(ト)−β−ヒドロキシ酪酸お
よびL(+)−β−ヒドロキシ吉草酸を工業的に有利に
生産でき、医薬品等の有用な合成中間体を供給できるよ
うになった。(Effects of the Invention) According to the present invention, optically active L(t)-β-hydroxybutyric acid and L(+)-β-hydroxyvaleric acid can be industrially advantageously produced, and useful synthetic intermediates for pharmaceuticals etc. can be supplied. It became so.
(実施例)
以下実施例により本発明を具体的に説明するが、本発明
はこれらの実施例のみに限定されるものではない。(Examples) The present invention will be specifically described below with reference to Examples, but the present invention is not limited to these Examples.
実施例1 グルコース40y、イーストエキス5y。Example 1 Glucose 40y, yeast extract 5y.
(NH4)2HPO413y、KH2PO479,Mg
SO4・7H200,8f、ZnSO4・7H2060
1n9.FeSO4・7H2090y、CuSO4・5
H2054,MnSO4’4820 1011tf、
NaCl O,ly、 酪酸10m/または吉草酸
101n!(11当り)の組成からなる培地をNaOH
でpH7,2となし、この31を51容ミニジャーファ
ーメンタ−に入れ殺菌後、キャンディダ°パラルゴーザ
(Candida pararugosa)IFO09
66あるイハソノ変異株KT 84015、マタはデバ
リオマイセス・ハンセンニ
(Debaryomyces hansenii) I
FO0032あるいはその変異株KT 84016を
植え、通気1vvm、撹拌500rpm、30℃で4日
間培養した。(NH4)2HPO413y, KH2PO479, Mg
SO4・7H200, 8f, ZnSO4・7H2060
1n9. FeSO4・7H2090y, CuSO4・5
H2054, MnSO4'4820 1011tf,
NaCl O,ly, butyric acid 10m/or valeric acid 101n! A medium consisting of a composition of (per 11) NaOH
Adjust the pH to 7.2, put this 31 in a 51 capacity mini jar fermentor, sterilize it, and add Candida pararugosa IFO09.
66 Ihasono mutant strain KT 84015, mata is Debaryomyces hansenii (Debaryomyces hansenii) I
FO0032 or its mutant strain KT 84016 was planted and cultured at 30° C. for 4 days with aeration of 1 vvm and stirring at 500 rpm.
培養中pHは7.0に保ち、かつ毎日グルコースを60
yずつ添加した。培養終了後、生成したL(+)−β−
ヒドロキシ酪酸あるいはL(ト)−β−ヒドロキシ吉草
酸を測定した結果、表−3の如くの蓄積が認められた。During cultivation, the pH was maintained at 7.0, and glucose was added at 60% daily.
y were added. After the completion of the culture, the produced L(+)-β-
As a result of measuring hydroxybutyric acid or L(t)-β-hydroxyvaleric acid, accumulation as shown in Table 3 was observed.
表 −3
XL(ト)−β−HBA:L(ト)−β−ヒドロキシ酪
酸L(ト)−β−HVA:L(ト)−β−ヒドロキシ吉
草酸尚、基質無添加の場合、いずれの株においてもL(
+)−β−ヒドロキシ酪酸あるいはL←)−β−ヒドロ
キシ吉草酸の蓄積は認められなかった。Table 3 XL(t)-β-HBA: L(t)-β-hydroxybutyric acid L(t)-β-HVA: L(t)-β-hydroxyvaleric acid. Even in stocks, L(
No accumulation of +)-β-hydroxybutyric acid or L←)-β-hydroxyvaleric acid was observed.
上記培養条件で得た培養液を除菌後、上清液を減圧下5
01ftまで濃縮し、次に硫酸でpH2,0とした。こ
れを酢酸エチル700−で3回抽出し、溶剤除去後、各
々L(ト)−β−ヒドロキシ脂肪酸を黄色油状で得た。After sterilizing the culture solution obtained under the above culture conditions, remove the supernatant solution under reduced pressure for 5 minutes.
The solution was concentrated to 0.01 ft and then adjusted to pH 2.0 with sulfuric acid. This was extracted three times with ethyl acetate, and after removing the solvent, each L(t)-β-hydroxy fatty acid was obtained in the form of a yellow oil.
これを減圧蒸留により精製し、表−4の如くの無色油状
のL(ト)−β−ヒドロキシ脂肪酸を得た。これらはN
MR,ガスクロ分析、詔よびメチルエステルにしたのち
の比旋光度測定により、酪酸からはL(ト)−β−ヒド
ロキシ酪酸、吉草酸からはL(+)−β−ヒドロキシ吉
草酸が得られることが確認された。This was purified by vacuum distillation to obtain a colorless oily L(t)-β-hydroxy fatty acid as shown in Table 4. These are N
According to MR, gas chromatography, and measurement of specific rotation after conversion to methyl ester, L(t)-β-hydroxybutyric acid can be obtained from butyric acid, and L(+)-β-hydroxyvaleric acid can be obtained from valeric acid. was confirmed.
以下余白
表 −4
実施例2
実施例1に示した培地から脂肪酸を除去した培地31を
5!容ミニジヤーフアメンターに入れ殺菌後、キャンデ
ィダ・パラルゴーザKT 84015あるいはデバリ
オマイセス・ハンセン二KT 84016を植菌し、
通気1vvm、撹拌500rpm、30℃で24時間培
養した。Margin table below -4 Example 2 Medium 31 obtained by removing fatty acids from the medium shown in Example 1 was used for 5! After sterilization by placing in a mini jar incubator, inoculate with Candida parargosa KT 84015 or Debaryomyces hansenji KT 84016,
Culture was carried out at 30° C. for 24 hours with aeration of 1 vvm and stirring of 500 rpm.
この培養波谷々に、クロトン酸、n−ブチルアルコール
、2−ペンテン酸あるいはn−アミルアルコールを15
2ずつ添加し、pHを7.0に保ちつつグルコースを毎
日60yずつ添加し、更に3日間反応させた。反応終了
後、生成したL(+)−β−ヒドロキシ脂肪酸をガスク
ロマトグラフィーで測定した結果、表−5の如くの各L
(ト)−β−ヒドロキシ脂肪酸の蓄積が認められた。Add 15% of crotonic acid, n-butyl alcohol, 2-pentenoic acid, or n-amyl alcohol to this culture wave.
Glucose was added at a rate of 60y each day while maintaining the pH at 7.0, and the reaction was continued for an additional 3 days. After the reaction, the L(+)-β-hydroxy fatty acids produced were measured by gas chromatography, and the results showed that each L
Accumulation of (g)-β-hydroxy fatty acids was observed.
表 −5
実施例3
実施例1と同様にキャンディダ・パラルゴーザKT
84015あるいはデバリオマイセス・ハンセン二 K
T 84016を培養し、培養開始後、24.48.
72時時間区グルコース60fまたはグリセロール60
yずつ添加し、かつpHを7.0に保ちつつ96時間培
養した。培養終了後の培養液中のL(+)−β−ヒドロ
キシ脂肪酸の生成量は表−6の如くであった。Table-5 Example 3 Same as Example 1, Candida paralgoza KT
84015 or Debaryomyces hansenii K
After culturing T 84016 and starting the culture, 24.48.
72 hours glucose 60f or glycerol 60
y were added and cultured for 96 hours while maintaining the pH at 7.0. The amount of L(+)-β-hydroxy fatty acid produced in the culture solution after completion of the culture was as shown in Table 6.
表 −6Table-6
Claims (8)
イセス(Debaryomyces)属に属し、酪酸を
L(+)−β−ヒドロキシ酪酸に変換する能力を有する
微生物から誘導されたL(+)−β−ヒドロキシ酪酸を
単一炭素源とする栄養培地に生育しないか、もしくは生
育の弱い変異株を炭素数4あるいは5の飽和脂肪酸、あ
るいはα,β−不飽和脂肪酸またはアルコールに作用さ
せ、生成する炭素数4あるいは5のL(+)−β−ヒド
ロキシ脂肪酸を採取することを特徴とするL(+)−β
−ヒドロキシ脂肪酸の製造法。(1) L(+)-β-hydroxybutyric acid derived from microorganisms that belong to the genus Candida and Debaryomyces and have the ability to convert butyric acid to L(+)-β-hydroxybutyric acid. A mutant strain that does not grow or grows poorly on a nutrient medium using a single carbon source is treated with saturated fatty acids having 4 or 5 carbon atoms, α,β-unsaturated fatty acids, or alcohol to produce 4 or 5 carbon atoms. L(+)-β characterized by collecting L(+)-β-hydroxy fatty acids of
- A method for producing hydroxy fatty acids.
dida pararugosa)あるいはデバリオマ
イセス・ハンセンニ(Debaryomyceshan
senii)から誘導された変異株である特許請求の範
囲第1項記載の製造法。(2) The microorganism is Candida paralgosa (Can
dida pararugosa) or Debaryomyces hansenii
3. The production method according to claim 1, which is a mutant strain derived from C. senii).
酸、α,β−不飽和脂肪酸がクロトン酸あるいは2−ペ
ンテン酸、アルコールがn−ブチルアルコールあるいは
n−アミルアルコールであり、製造目的物がそれぞれ対
応するL(+)−β−ヒドロキシ酪酸、あるいはL(+
)−β−ヒドロキシ吉草酸である特許請求の範囲第1項
あるいは第2項記載の製造法。(3) The saturated fatty acid used as a substrate is butyric acid or valeric acid, the α,β-unsaturated fatty acid is crotonic acid or 2-pentenoic acid, and the alcohol is n-butyl alcohol or n-amyl alcohol, each corresponding to the target product. L(+)-β-hydroxybutyric acid, or L(+
)-β-hydroxyvaleric acid.
作用させる特許請求の範囲第1項、第2項あるいは第3
項記載の製造法。(4) Claims 1, 2 or 3 in which microorganisms are cultured in a nutrient medium and a substrate is applied to the obtained culture solution.
Manufacturing method described in section.
用させる特許請求の範囲第1項、第2項あるいは第3項
記載の製造法。(5) The production method according to claim 1, 2, or 3, wherein the method is cultured in a medium to which a substrate is added, and the substrate and microorganisms are allowed to interact with each other.
微生物菌体を分離して菌体懸濁液を調製し、それに基質
を作用させる特許請求の範囲第1項、第2項あるいは第
3項記載の製造法。(6) A microorganism is cultured in a nutrient medium, the microorganism cells are separated from the obtained culture solution to prepare a cell suspension, and a substrate is applied to the cell suspension. The manufacturing method described in paragraph 3.
しうるエネルギー源を補給する特許請求の範囲第1項乃
至第6項の何れかの項記載の製造法。(7) The production method according to any one of claims 1 to 6, wherein an energy source that can be used by the microorganism is supplied when the microorganism and the substrate are allowed to interact with each other.
たはグリセロールである特許請求の範囲第7項記載の製
造法。(8) The production method according to claim 7, wherein the energy source that can be used by the microorganism is glucose or glycerol.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2584285A JPS61185193A (en) | 1985-02-13 | 1985-02-13 | Production of l(+)-beta-hydroxyfatty acid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2584285A JPS61185193A (en) | 1985-02-13 | 1985-02-13 | Production of l(+)-beta-hydroxyfatty acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61185193A true JPS61185193A (en) | 1986-08-18 |
| JPH048036B1 JPH048036B1 (en) | 1992-02-13 |
Family
ID=12177100
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2584285A Pending JPS61185193A (en) | 1985-02-13 | 1985-02-13 | Production of l(+)-beta-hydroxyfatty acid |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61185193A (en) |
-
1985
- 1985-02-13 JP JP2584285A patent/JPS61185193A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JPH048036B1 (en) | 1992-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009148211A (en) | Fermentation production method of D-arabitol and microorganism used for the implementation | |
| JPH0775589A (en) | Method for producing protocatechuic acid | |
| JPS6257313B2 (en) | ||
| US4540665A (en) | Process for producing D-β-hydroxyalkanoic acid | |
| JPH01277495A (en) | Biological conversion of l-thirosine and l-phenylalanin to 2, 5-dihydroxyphenyl acetic acid | |
| JPS61185193A (en) | Production of l(+)-beta-hydroxyfatty acid | |
| JPH03191794A (en) | Production of r-(-)-3-halogeno-1,2-propanediol by microbial treatment | |
| JPH0714355B2 (en) | Method for preparing L-carnitine | |
| JP4303526B2 (en) | (-)-2-Deoxy-shiro-inosose production method | |
| JPH048035B2 (en) | ||
| JPS6142560B2 (en) | ||
| JPS6319153B2 (en) | ||
| JPH03191795A (en) | Production of s-(+)-3-halogeno-1,2-propanediol by microorganismic treatment | |
| JPS6142559B2 (en) | ||
| JP2991395B2 (en) | 5-Aminolevulinic acid-producing microorganism and method for producing 5-aminolevulinic acid | |
| JPS58224693A (en) | Preparation of d(-)-beta-hydroxyvaleric acid | |
| JPS60114187A (en) | Novel bacterium | |
| JPH06277078A (en) | Method for producing parahydroxybenzaldehyde | |
| JP2670130B2 (en) | Method for culturing Rhodococcus bacteria and method for producing 2-ketobutyric acid using the microorganism | |
| JP2715260B2 (en) | New green algae, new yeast, and method for producing 2,6-naphthalenedicarboxylic acid using the green algae or the yeast | |
| JPH02257874A (en) | Bacterial strain of genus rhodococcus and production of 2-hydroxybutyric acid using the same | |
| JPH07206886A (en) | Farnesyl transferase inhibitor FO-3929 substance and method for producing the same | |
| JPS60153797A (en) | Fermentative production of mevalonic acid | |
| JPS6047677A (en) | Novel microorganism | |
| JPS62257391A (en) | Production of palmitoleic acid by fermentation method |